Advances in Chronic Kidney Disease
Volume 15, Issue 3 , Pages 278-283 , July 2008

Progression From Acute Kidney Injury to Chronic Kidney Disease: A Pediatric Perspective

References 

  1. Andreoli SP. Acute renal failure. Curr Opin Pediatr. 2002;14:183–188
  2. Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis. 2005;45:96–101
  3. Warady BA, Bunchman T. Dialysis therapy for children with acute renal failure: Survey results. Pediatr Nephrol. 2005;15:11–13
  4. Vachvanichsanong P, Dissaneewate P, Lim A, et al. Childhood acute renal failure: 22-year experience in a university hospital in southern Thailand. Pediatrics. 2006;118:e786–e791
  5. Bailey D, Phan V, Litalien C, Ducruet T, et al. Risk factors of acute renal failure in critically ill children: A prospective descriptive epidemiological study. Pediatr Crit Care Med. 2007;8:29–35
  6. Akcan-Arikan A, Zappitelli M, Loftis LL, et al. Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int. 2007;71:1028–1035
  7. Chan KL, Ip P, Chiu CS, et al. Peritoneal dialysis after surgery for congenital heart disease in infants and young children. Ann Thorac Surg. 2003;76:1443–1449
  8. Skippen PW, Krahn GE. Acute renal failure in children undergoing cardiopulmonary bypass. Crit Care Resusc. 2005;7:286–291
  9. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231–1238
  10. Dent CL, Ma Q, Dastrala S, et al. Plasma NGAL predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: A prospective uncontrolled cohort study. Crit Care. 2007;11:R127
  11. Bennett M, Dent CL, Ma Q, et al. Urine NGAL predicts severity of acute kidney injury after cardiac surgery: A prospective study. Clin J Am Soc Nephrol. 2008;3:665–673
  12. Kist-van Holthe JE, Goedvolk CA, Brand R, et al. Prospective study of renal insufficiency after bone marrow transplantation. Pediatr Nephrol. 2002;17:1032–1037
  13. Kellum JA, Angus DC. Patients are dying of acute renal failure. Crit Care Med. 2002;30:2156–2157
  14. Chertow GM, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16:3365–3370
  15. Price JF, Mott AR, Dickerson HA, et al: Worsening renal function in children hospitalized with acute decompensated heart failure: Evidence for a pediatric cardiorenal syndrome? Ped Crit Care Med (in press)
  16. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure—Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8:R204–R212
  17. Abosaif NY, Tolba YA, Heap M, et al. The outcome of acute renal failure in the intensive care unit according to RIFLE: Model application, sensitivity, and predictability. Am J Kidney Dis. 2005;46:1038–1048
  18. Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis. Crit Care. 2006;10:R73
  19. Kuitunen A, Vento A, Suojaranta-Ylinen R, et al. Acute renal failure after cardiac surgery: evaluation of the RIFLE classification. Ann Thorac Surg. 2006;81:542–546
  20. Uchino S, Bellomo R, Goldsmith D, et al. An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med. 2006;34:1913–1917
  21. Michael M, Kuehnle I, Goldstein SL. Fluid overload and acute renal failure in pediatric stem cell transplant patients. Pediatr Nephrol. 2004;19:91–95
  22. D'Amico G. Comparability of the different registries on renal replacement therapy. Am J Kidney Dis. 1995;25:113–118
  23. Seikaly MG, Ho PL, Emmett L, et al. Chronic renal insufficiency in children: The 2001 Annual Report of the NAPRTCS. Pediatr Nephrol. 2003;18:796–804
  24. Furth SL, Cole SR, Moxey-Mims M, et al. Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol. 2006;1:1006–1015
  25. Hui-Stickle S, Brewer ED, Goldstein SL. Pediatric ARF Epidemiology at a Teritary Care Center from 1999 to 2001. Am J Kidney Dis. 2005;45:96–101
  26. Askenazi DJ, Feig DI, Graham NM, et al. 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int. 2006;69:184–189
  27. Gilbertson DT, Liu J, Xue JL, et al. Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16:3736–3741
  28. Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens. 2008;17:127–132
  29. Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: A position statement from the National Kidney Foundation. Am J Kidney Dis. 2007;50:169–180
  30. Devarajan P, Parikh CR, Barasch J. Letter to the editor. N Engl J Med. 2008;358:312
  31. Devarajan P. Proteomics for biomarker discovery in acute kidney injury. Semin Nephrol. 2007;27:637–651
  32. Edelstein CL. Biomarkers of acute kidney injury. Adv Chronic Kidney Dis. 2008;15:222–234
  33. Mishra J, Ma Q, Prada A, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol. 2003;14:2534–2543
  34. Supavekin S, Zhang W, Kucherlapati R, et al. Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 2003;63:1714–1724
  35. Mishra J, Mori K, Ma Q, et al. Neutrophil gelatinase-associated lipocalin: A novel early urinary biomarker for cisplatin nephrotoxicity. Am J Nephrol. 2004;24:307–315
  36. Mishra J, Ma Q, Kelly C, et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol. 2006;21:856–863
  37. Parikh CR, Jani A, Mishra J, et al. Urine NGAL and IL-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant. 2006;6:1639–1645
  38. Trachtman H, Christen E, Canaan A, et al. Urinary NGAL in D+HUS: A novel marker of renal injury. Pediatr Nephrol. 2006;21:989–994
  39. Hirsch R, Dent C, Pfriem H, et al. NGAL is an early predictive biomarker of contrast-induced nephropathy in children. Pediatr Nephrol. 2007;22:2089–2095
  40. Zappitelli M, Washburn KK, Arikan AA, et al. Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: A prospective cohort study. Crit Care. 2007;11:R84
  41. Mitsnefes MM, Kathman TS, Mishra J, et al. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease. Pediatr Nephrol. 2007;22:101–108
  42. Bolignano D, Coppolino G, Campo S, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transplant. 2008;23:414–416
  43. Bolignano D, Coppolino G, Campo S, et al. Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol. 2007;27:373–378
  44. Ding H, He Y, Li K, et al. Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol. 2007;23:227–234
  45. Brunner HI, Mueller M, Rutherford C, et al. Urinary NGAL as a biomarker of nephritis in childhood-onset SLE. Arthritis Rheum. 2006;54:2577–2584
  46. Negishi K, Noiri E, Sugaya T, et al. A role of liver fatty acid binding protein in cisplatin-induced acute renal failure. Kidney Int. 2007;72:348–358
  47. Yamamoto T, Noiri E, Ono Y, et al. Renal L-type fatty acid–binding protein in acute ischemic injury. J Am Soc Nephrol. 2007;18:2894–2902
  48. Portilla D, Dent C, Sugaya T, et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2008;73:465–472
  49. Kamijo A, Sugaya T, Hikawa A, et al. Urinary liver-type fatty acid binding protein as a useful biomarker in chronic kidney disease. Mol Cell Biochem. 2006;284:175–182
  50. Zhang Z, Humphreys BD, Bonventre JV. Shedding of the urinary biomarker kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region. J Am Soc Nephrol. 2007;18:2704–2714
  51. Han WK, Bailly V, Abichandani R, et al. Kidney injury molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney Int. 2002;62:237–244
  52. Han WK, Waikar SS, Johnson A, et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int. 2008;73:863–869
  53. van Timmeren MM, van den Heuvel MC, Bailly V, et al. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol. 2007;212:209–217
  54. van Timmeren MM, Vaidya VS, van Ree RM, et al. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. Transplant. 2007;84:1625–1630

PII: S1548-5595(08)00054-2

doi: 10.1053/j.ackd.2008.04.007

Advances in Chronic Kidney Disease
Volume 15, Issue 3 , Pages 278-283 , July 2008

Article Tools